Published in World Neurosurg on April 04, 2012
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma (SAS-GKRS) | NCT04205357
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc(-), leading to glutathione depletion. Oncogene (2015) 0.94
Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study. Onco Targets Ther (2014) 0.83
Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int (2014) 0.79
Recurrent malignant gliomas. Semin Radiat Oncol (2014) 0.79
Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma. World J Clin Oncol (2014) 0.78
Stereotactic Radiosurgery for Glioblastoma. Cureus (2015) 0.78
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. Expert Rev Anticancer Ther (2016) 0.78
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience. Neurosurgery (2016) 0.77
Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature. Case Rep Oncol Med (2013) 0.77
Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model. Biomed Res Int (2013) 0.77
Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis. Neurol Sci (2015) 0.76
Outcomes after stereotactic radiosurgery and various adjuvant treatments for recurrent glioblastoma multiforme: a current literature review and comparison of multiple factors that impact outcome. World Neurosurg (2012) 0.76
Stereotactic radiosurgery for glioblastoma--time to revisit this approach. World Neurosurg (2012) 0.76
Management of Gliomas: Overview of the Latest Technological Advancements and Related Behavioral Drawbacks. Behav Neurol (2015) 0.75
Re-irradiation alternatives for recurrent high-grade glioma. Oncol Lett (2016) 0.75
MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. J Neurooncol (2017) 0.75
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A (2011) 3.48
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer (2008) 3.46
Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. World Neurosurg (2012) 2.03
Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A (2006) 1.96
Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery (2009) 1.77
In vivo animal models for studying brain metastasis: value and limitations. Clin Exp Metastasis (2013) 1.52
[Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Laegeforen (2011) 1.45
Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg (2011) 1.38
A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J (2008) 1.29
Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res (2010) 1.24
In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol (2012) 1.21
NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin. FASEB J (2002) 1.18
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery (2005) 1.16
Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume. J Physiol (2009) 1.12
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmunol (2013) 1.08
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One (2011) 1.05
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Oncotarget (2013) 0.99
Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg (2015) 0.95
Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res (2013) 0.94
Cancer stem cells in the central nervous system--a critical review. Cancer Res (2010) 0.92
Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol (2007) 0.92
Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors. Hum Gene Ther (2002) 0.92
Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer (2011) 0.92
Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects. Int J Cancer (2007) 0.91
Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Exp Cell Res (2010) 0.90
Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed (2008) 0.87
Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. Clin Cancer Res (2008) 0.87
Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery (2012) 0.87
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. J Nucl Med (2012) 0.86
Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Exp Neurol (2008) 0.85
[Treatment of cerebrovascular disease in a comprehensive stroke unit]. Tidsskr Nor Laegeforen (2011) 0.85
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med (2014) 0.85
Comparison of effective radiation doses in patients undergoing unenhanced MDCT and excretory urography for acute flank pain. AJR Am J Roentgenol (2007) 0.84
Antitumor efficacy improved by local delivery of species-specific endostatin. J Neurosurg (2006) 0.80
Cerebral atypical teratoid/rhabdoid tumor of infancy: long-term survival after multimodal treatment, also including triple intrathecal chemotherapy and gamma knife radiosurgery--case report. Pediatr Hematol Oncol (2003) 0.80
Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. J Neurooncol (2006) 0.80
A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics. Ann Biomed Eng (2013) 0.79
Gamma knife treatment of growing vestibular schwannoma in Norway: a prospective study. Int J Radiat Oncol Biol Phys (2012) 0.78
Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model. Biomed Res Int (2013) 0.77
Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. Curr Pharm Biotechnol (2002) 0.77
Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments. Cancer Invest (2013) 0.77
Gamma knife stereotactic radiosurgery of Nelson syndrome. Eur J Endocrinol (2008) 0.76
Gamma-knife radiosurgery in pediatric cerebral and skull base tumors. Med Pediatr Oncol (2003) 0.75
[Stereotactic radiosurgery of cerebral arteriovenous malformations]. Tidsskr Nor Laegeforen (2002) 0.75
[Treatment of acoustic neuroma]. Tidsskr Nor Laegeforen (2002) 0.75